Yüklüyor......
Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9)
BACKGROUND: Abnormalities in lipid and glucose metabolism are constantly observed in type 2 diabetes. However, these abnormalities can be ameliorated by polydatin. Considering the important role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in metabolic diseases, we explore the possible m...
Kaydedildi:
| Yayımlandı: | Cardiovasc Diabetol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736185/ https://ncbi.nlm.nih.gov/pubmed/26833058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0325-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|